High altitude pulmonary oedema

Journal of the Royal Army Medical Corps

Volumn 157, Issue 1, 2011, Pages 68-72

  Hall, D P ^a   Duncan, K ^b   Baillie, J K ^c  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b University of Edinburgh ^*

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTITUDE DISEASE; HUMAN; LUNG EDEMA; MOUNTAINEERING; PHYSIOLOGY; REVIEW;

ALTITUDE SICKNESS; HUMANS; MOUNTAINEERING; PULMONARY EDEMA;

EID: 79956325122     PISSN: 00358665     EISSN: None     Source Type: Journal    
DOI: 10.1136/jramc-157-01-12     Document Type: Article

References (62)

1. West J. The physiologic basis of high-altitude diseases. Ann Intern Med 2004; 141: 789.
2. Hackett P, Roach R High altitude medicine. In: Auerbach P, editor. Wilderness Medicine. St. Louis: Mosby, 2001; pp. 2-43.
3. McIntosh S, Campbell A, Dow J, Grissom C. Mountaineering fatalities on Denali. High Alt Med Biol 2008; 9: 89-95.
4. Cremona G, Asnaghi R, Baderna P et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 2002;359: 303-309.
5. Houston CS. Acute Pulmonary Edema of High Altitude. N Engl J Med 1960; 263: 478-480.
6. Maggiorini M, Buhler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990; 301: 853-855.
7. Sophocles AM, Jr. High-altitude pulmonary edema in Vail, Colorado, 1975-1982. West J Med 1986;144: 569-573.
8. Hultgren H, Honigman B, Teis K, Nicholas D. High-altitude pulmonary edema at a ski resort. West J Med 1996; 164: 222.
9. Gabry AL, Ledoux X, Mozziconacci M, Martin C. High-Altitude Pulmonary Edema at Moderate Altitude (< 2,400 m; 7,870 feet). Chest 2003; 123: 49-53.
10. Kobayashi T, Koyama S, Kubo K, Fukushima M, Kusama S. Clinical features of patients with high- altitude pulmonary edema in Japan. Chest 1987;92: 8140821.
11. Bärtsch P, Mairbaurl H, Swenson ER, Maggiorini M. High altitude pulmonary oedema. Swiss Med Wkly 2003; 133: 377-384.
12. Droma Y, Hanaoka M, Ota M et al. Positive Association of the Endothelial Nitric Oxide Synthase Gene Polymorphisms With High-Altitude Pulmonary Edema. Circulation 2002; 106: 826-830.
13. Smith EMD, Baillie JK, Tompson AAR et al. Endothelial Nitric Oxide Synthase Polymorphisms Do Not Infuence Pulmonary Artery Systolic Pressure at Altitude. High Alt Med Biol 2006; 7: 221-227.
14. International HAPE Database Available online at http://www.altitude.org/hape.php [accessed 24/11/2010].
15. Basnyat B, Subedi D, Sleggs J et al. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ Med 2000; 11: 89-93.
16. Hackett P, Rennie D, Levine H. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976; 308: 1149-1155.
17. Bärtsch P, Maggiorini M, Mairbäurl H, Vock P, Swenson ER. Pulmonary extravascular fluid accumulation in climbers. Lancet 2002; 360: 571.
18. Purkayastha SS, Ray US, Arora BS et al. Acclimatization at high altitude in gradual and acute induction. J Appl Physiol 1995; 79: 487-492.
19. Ren Y, Fu Z, Shen W et al. Incidence of High Altitude Illnesses among Unacclimatized Persons Who Acutely Ascended to Tibet. High Alt Med Biol 2010; 11: 39-42.
20. Hultgren HN, Marticorena EA. High altitude pulmonary edema. Epidemiologic observations in Peru. Chest 1978; 74: 372-376.
21. Bärtsch P. High altitude pulmonary edema. Med Sci Sports Exerc 1999; 31: S23-S27.
22. Pratali L, Cavana M, Sicari R, Picano E. Frequent subclinical high-altitude pulmonary edema detected by chest sonography as ultrasound lung comets in recreational climbers. Crit Care Med 2010; 38: 1818-1823.
23. Basnyat B, Murdoch D. High-altitude illness. Lancet 2003; 361: 1967-1974.
24. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345: 107-114.
25. Zafren K, Reeves J, Schoene R. Treatment of high-altitude pulmonary edema by bed rest and supplemental oxygen. Wilderness Environ Med 1996; 7: 127-132.
26. Jackson SJ, Varley J, Sellers C et al. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Alt Med Biol 2010; 11: 217-222.
27. Windsor J, Firth P, Grocott M, Rodway G, Montgomery H. Mountain mortality: a review of deaths that occur during recreational activities in the mountains. Postgrad Med J 2009; 85: 316.
28. Firth P, Zheng H, Windsor J et al. Mortality on Mount Everest, 1921-2006: descriptive study. BMJ 2008; 337: a2654.
29. Tompson AA, Baillie JK, Bates MG et al. The citric acid cough threshold and the ventilatory response to carbon dioxide on ascent to high altitude. Respir Med. 2009; 103(8):1182-1188.
30. Vock P, Fretz C, Franciolli M, Bartsch P. High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology 1989; 170: 661-666.
31. Sartori C, Allemann Y, Trueb L et al. Exaggerated pulmonary hypertension is not sufcient to trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr 2000; 130: 385-389.
32. Maggiorini M, Melot C, Pierre S et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103: 2078-2083.
33. Scherrer U, Rexhaj E, Jayet P, Allemann Y, Sartori C. New Insights in the Pathogenesis of High-Altitude Pulmonary Edema. Prog Cardiovasc Dis 2010; 52: 485-492.
34. Hultgren HN, Grover RF, Hartley LH. Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High-Altitude Pulmonary Edema. Circulation 1971; 44: 759-770.
35. West JB, Mathieu Costello O., High Altitude Pulmonary Edema is Caused by Stress Failure of Pulmonary Capillaries. Int J Sports Med 1992; 13: S54-S58.
36. Bachofen H, Schurch S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs. Barrier lesions. Am Rev Respir Dis 1993; 147: 997-1004.
37. Tompson AAR, Baillie JK, Toshner M et al. Pericardial effusions in healthy lowlanders after acute ascent to high altitude. Heart 2006; 92:539-40.
38. Scherrer U, Vollenweider L, Delabays A et al. Inhaled Nitric Oxide for High-Altitude Pulmonary Edema. N Engl J Med 1996; 334: 624-630.
39. Stream JO, Grissom CK. Update on High-Altitude Pulmonary Edema: Pathogenesis, Prevention, and Treatment. Wilderness Environ Med 2008; 19: 293-303.
40. Swenson ER, Maggiorini M, Mongovin S et al. Pathogenesis of High-Altitude Pulmonary Edema: Infammation Is Not an Etiologic Factor. JAMA 2002; 287: 2228-2235.
41. Duplain H, Sartori C, Lepori M et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against infammation. Am J Respir Crit Care Med 2000; 162: 221-224.
42. Busch T, Bartsch P, Pappert D et al. Hypoxia Decreases Exhaled Nitric Oxide in Mountaineers Susceptible to High-Altitude Pulmonary Edema. Am J Respir Crit Care Med 2001; 163: 368-373.
43. Berger MM, Hesse C, Dehnert C et al. Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema. Am J Respir Crit Care Med 2005; 172: 763-767.
44. Sartori C, Vollenweider L, Lofer B-M et al. Exaggerated Endothelin Release in High-Altitude Pulmonary Edema. Circulation 1999; 99: 2665-2668.
45. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
46. Duplain H, Vollenweider L, Delabays A et al. Augmented Sympathetic Activation During Short-Term Hypoxia and High-Altitude Exposure in Subjects Susceptible to High-Altitude Pulmonary Edema. Circulation 1999; 99: 1713-1718.
47. Scherrer U, Vollenweider P, Randin D et al. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993; 88: 388-394.
48. Sartori C, Allemann Y, Duplain H et al. Salmeterol for the Prevention of High-Altitude Pulmonary Edema. N Engl J Med 2002; 346: 1631-1636.
49. Luks AM, McIntosh SE, Grissom CK et al. Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness. Wilderness Environ Med 2010; 21: 146-155.
50. Bates MG, Tompson AA, Baillie JK. Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema. Curr Opin Investig Drugs 2007; 8(3):226-31.
51. Levine BD, Yoshimura K, Kobayashi T et al. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321: 1707-1713.
52. Baillie JK, Tompson AA, Irving JB et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial QJM 2009; 102(5):341-348.
53. Maggiorini M, Brunner-La Rocca H P, Peth S et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145: 497-506.
54. van Patot MCT, Leadbetter G, Keyes LE et al. Prophylactic Low-Dose Acetazolamide Reduces the Incidence and Severity of Acute Mountain Sickness. High Alt Med Biol 2008; 9: 289-293.
55. Basnyat B, Gertsch JH, Johnson EW et al. Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial. High Alt Med Biol 2003; 4: 45-52.
56. Grissom CK, Roach RC, Sarnquist FH, Hackett PH. Acetazolamide in the treatment of acute mountain sickness: clinical Efficacy and effect on gas exchange. Ann Intern Med 1992; 116: 461-465.
57. Hohne C, Krebs MO, Seiferheld M et al. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs. J Appl Physiol 2004; 97: 515-521.
58. Teppema LJ, Balanos GM, Steinback CD et al. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med 2007; 175: 277-281.
59. Anand IS, Prasad BA, Chugh SS et al. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation 1998; 98: 2441-2445.
60. Schoene RB, Roach RC, Hackett PH, Harrison G, Mills WJ., High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest 1985; 87: 330-333.
61. Richalet J P, Gratadour P, Robach P et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med 2005; 171: 275-281.
62. Bärtsch P, Maggiorini M, Ritter M et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991; 325(18): 1284-1289.